Drug intelligence / Profile preview

nitrates + clopidogrel + aspirin + statins

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral, Sublingual, Transdermal, Intravenous, Topical, Rectal
01

Overview

This is a combination therapy consisting of four classes of cardiovascular drugs: - **Nitrates** (e.g., glyceryl trinitrate, isosorbide mononitrate): Vasodilators that relax and widen blood vessels, improving blood flow to the heart and relieving angina symptoms. - **Clopidogrel**: An antiplatelet agent (P2Y12 inhibitor) that prevents platelets from sticking together, reducing the risk of clot formation. - **Aspirin**: An antiplatelet agent that inhibits platelet aggregation by blocking cyclooxygenase, further reducing clot risk. - **Statins** (e.g., atorvastatin, simvastatin): Lipid-lowering agents that inhibit HMG-CoA reductase to reduce cholesterol synthesis in the liver and lower LDL cholesterol. This combination targets multiple mechanisms involved in coronary artery disease and acute coronary syndromes. It is commonly used for secondary prevention after myocardial infarction or in patients with stable angina or high cardiovascular risk. The regimen reduces recurrent ischemic events by addressing thrombosis (aspirin/clopidogrel), hyperlipidemia (statins), and myocardial oxygen supply/demand imbalance (nitrates)[1][3][4][5].

02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)P2Y12 (Purinergic P2Y12 receptor)sGC (Soluble Guanylyl Cyclase)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on nitrates + clopidogrel + aspirin + statins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitrates + clopidogrel + aspirin + statins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call